🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

ADM names 3M's Patolawala as its CFO amid US government investigation

Published 07/10/2024, 06:50 AM
Updated 07/10/2024, 11:36 AM
© Reuters. FILE PHOTO: The company logo and trading information for 3M is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., November 29, 2022.  REUTERS/Brendan McDermid/File Photo
MMM
-

(Reuters) -Archer-Daniels-Midland named manufacturing giant 3M's Monish Patolawala as its CFO on Wednesday, as the grain trader tries to steer its way through multiple U.S. government investigations related to accounting irregularities.

Patolawala's appointment at ADM will be effective Aug. 1, the company said. He will succeed interim CFO Ismael Roig, who has been serving in his role since January 2024.

In March, ADM had corrected six years of financial data after an internal investigation found some sales between business units within the company were not recorded properly.

ADM had put its then CFO Vikram Luthar on administrative leave in January before announcing his departure from the company in April.

"I think the move signals the board wanted to hire an outside CFO candidate as a way to start fresh following the accounting issues," Morningstar analyst Seth Goldstein said.

ADM said Patolawala would have an initial annual base salary of $1.425 million.

3M shares were down while ADM was up marginally in morning trade.

Some Wall Street analysts said Patolawala's departure from 3M was expected as he was likely passed over for the role of CEO for industry veteran Bill Brown.

© Reuters. Archer Daniels Midland Co (ADM) logo is seen displayed in this illustration taken, April 10, 2023. REUTERS/Dado Ruvic/Illustration/File photo

"We thought highly of Monish, and consider his four-year tenure at 3M to have been a success with clear and consistent messaging and the smoothly orchestrated Health Care spin," RBC Capital Markets analyst Deane Dray wrote in a note.

3M rolled out a major restructuring last year that includes cutting thousands of jobs and the spinoff of its healthcare business into a listed company, to mitigate the slowdown in demand.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.